|Articles|October 15, 2015

NYU Doctors Explain DCIS

Last month, we got the chance to discuss DCIS with three doctors from NYU Cancer Center: Dr. Deborah Axelrod, Dr. Julia Smith, and Dr. David Kleinberg.

They explain what DCIS is, discuss public trials and future directions for DCIS, and address some current controversies around the diagnosis.

Listen to the talk here:

Knowledge is power. Don’t miss the most recent breakthroughs in cancer care.

Related to this article

September 24th, 2026

FDA Approves Belzutifan Plus Lenvatinib for Advanced Clear Cell RCC

FDA approves belzutifan with lenvatinib for advanced clear cell RCC after PD-1/PD-L1 inhibitor failure. Review LITESPARK-011 data and nursing takeaways.

September 24th, 2026

Reframing Nurse Fatigue as Systemic Safety Risk

ANA President Jennifer Mensik Kennedy outlines systemic nurse fatigue mitigation policies, emphasizing patient safety and acuity across oncology care.

September 24th, 2026

ICN 2026: APP Leadership, Cancer Pain Care, and Nurse-Led Rapid Care Models

From ICN 2026, Heather Jackson and Ashley Johnson detail APP breast care access models, global cancer pain barriers, and burnout mitigation tactics.

September 23rd, 2026

FDA Approves Lirafugratinib for Advanced FGFR2+ Cholangiocarcinoma

FDA approves lirafugratinib (Lyrfigtu) for FGFR2+ cholangiocarcinoma. Review REFOCUS trial data, 70 mg daily dosing, and nursing safety guidelines.

September 23rd, 2026

How On-Body Treatment Delivery Reduces Nursing Burden in Myeloma Care

Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinical trials and nursing impacts of on-body isatuximab delivery in multiple myeloma.

September 23rd, 2026

Delirium and Capacity in Cancer: Dr. Yesne Alici on Bioethics and Clinical Care

Yesne Alici, MD, of Memorial Sloan Kettering Cancer Center discusses key delirium screening, patient capacity, and bioethics in oncology nursing care.